* If you want to update the article please login/register
Patients at intermediate stroke risk based on CHA 2 DS 2 -VASc score was investigated by this research to determine the correlation between the frequency of cardioversions as a measure of clinical AF burden on the long-term SSE risk. Additional risk stratification in patients with frequent episodes of clinical arrhythmia can be used in patients with a low risk of stroke in AF patients with a CHA 2 DS 2 -VASc score, according to CHA 2 DS 2 –VASc patients with an elevated risk of stroke. CHA 2 DS 2 -VASc results can be used to determine additional risk stratification in patients with a moderate risk of stroke. CHA 2 DS 2 DS 2 CHA 2 CHA 2 CHA 2 CHA 2 AF patients with AF patients with AF patients with AF patients with CHA 2 AF patients with CHA 2 CHA 2 CHA 2 based on CHA 2 RASc patient with CHA 2 CHA 2 VSCI risk of stroke bact CHA 2 CHA 2 CHA 2 CHA 2 CHA 2 CHA 2 &VASc score CHA 2 MED 2 based on CHA 2 RASc patient with CHA 2 HS2 CHA 2 MED 2 HS2 CHA 2 DS 2 vsc CHA 2.
Source link: https://europepmc.org/article/MED/35594342
In patients without cardiac arrestrhythmia, CHA 2 DS 2 -VASc ratings may be related to brain function in patients with cardiac arrhythmia. Our analysis shows that a combination of risk factors embedded in a well-established risk score correlated with brain tissue volume independently of the presence of an arrhythmia.
Source link: https://europepmc.org/article/MED/35549584
Objectives The aim of this report was to determine the cost-effectiveness of intermittent electrocardiogram (Atrial fibrillation) testing in primary care among 70-74-year-old people. Methods A post hoc analysis based on a cross-sectional screening report for AF among 70-74-year-old patients, who were registered at a single primary care facility in a single geographic area, was followed for three years for mortality. Conclusions The mortality rate in screening-detected AF cases did not differ from those in 274 people with no AF. The incremental cost-effectiveness ratio of screening versus no screening was EUR 2389/quality-adjusted life year increased. The screening revealed a 99% likelihood of being cost-effective relative to no screening at a willingness-to-pay threshold of EUR 20,000 per QALY. Screening for AF among 70-74-year olds in primary care using intermittent ECG appears to be cost-effective in a 3-year follow-up with high anticoagulants adherence and no rise in mortality among 70-74-year olds.
Source link: https://europepmc.org/article/MED/35389311
Background In various clinical conditions, red blood cell distribution width has emerged as a prognostic marker of atrial fibrillation. However, the connection between RDW and AF in hemodialysis patients was not clear. In HD patients, we wanted to find the connection between RDW and AF occurrence. To determine the independent predictors of AF occurrence in HD patients, a multivariable logistic regression analysis was carried out. In the AF group, there were no paroxysmal AF patients. Patients with AF group had a significantly older age, lower BMI, elevated RDW, and larger LAD relative to the non-AF group. With a sensitivity of 68. 6% and a specificity of 72. 6%, the highest RDW cutoff value to predict AF occurrence was 14. 65%. Conclusions The increased RDW was highly correlated with the paroxysmal AF occurrence in HD patients, according to the authors.
Source link: https://europepmc.org/article/MED/35156896
The prevalence of atrial fibrillation in Greenland is determined by either single-point electrocardiograms or patients admitted with stroke. For the 790 patients identified in the EMR, descriptive data and sample laboratory results were extracted, and a minimum CHA 2 DS 2 -VASc score was calculated. The prevalence of AF in this study is higher than that found in previous studies in Greenland and comparable to those found in other Western countries, indicating that AF is common in Greenland.
Source link: https://europepmc.org/article/MED/35086441
Background: Although multiple myeloma patients have been shown to have the highest risk of atrial fibrillation in comparison to other cancer patients, epidemiological studies are lacking on the effect of atrial fibrillation on health outcomes in this population. In this research, we investigated the effects of atrial fibrillation on hospitalized patients with MM. Compared to those without atrial fibrillation, MM patients with atrial fibrillation had 1. 2 times higher odds of inpatient all-cause mortality. MM patients who were not using anticoagulation also had poor health outcomes, according to higher odds of inpatient all-cause mortality (AOR = 1. 40; 95endmatheq 18,077. 3; 95% CI = 11,467. 8- 18,077. 3). Conclusions These findings emphasize the importance of monitoring and potential screening to detect atrial fibrillation in MM patients, as anticoagulation may reduce mortality in these patients.
Source link: https://europepmc.org/article/MED/PMC9217100
We therefore wanted to investigate the connection between APOA1 and AF by sex in the Chinese population. 950 patients with AF who were hospitalized consecutively between January 2019 and September 2021 were included in this case-control study. Pearson correlation analysis was used to determine the relationship between APOA1 and blood lipid profiles. AF patients with low APOA1 were strongly linked to AF, both male and female, despite statin use. The serum APOA1 was positively correlated with total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoprotein B, according to a Pearson correlation study, and apolipoprotein B. The most suitable cut-off values for predicting AF were APOA1 levels=1. 105 g/L in male and APOA1 levels=1. 205 g/L, according to ROC curve analysis. Conclusion: Low APOA1 in male and female patients is strongly related to AF in the Chinese population.
Source link: https://europepmc.org/article/PPR/PPR510217
Aims The analysis of heart rate changes, such as HR variability or HR turbulence, has been published as a predictor of cardiovascular events during sinus rhythm; however, those relationships during atrial fibrillation remain unclear, and they are not widely used in AF patients. We wanted to investigate the relationship between a simple index focusing on the HR and heart failure events in patients with permanent AF. Methods and findings We enrolled 198 patients with permanent AF and assessed the HR range, defined as the highest HR minus the minimum HR on 24-h Holter electrocardiogram recordings, plus the minimum HR on 24-h Holter electrocardiogram recordings. Due to exacerbations of one's HF status, hospitalizations for HF or urgent hospital visits were designated as hospitalizations for HF or urgent hospital visits. The larger HRR group had more HF events than the smaller HRR group in a log-rank comparison. Model 2, adjusted hazard ratio = 3. 6, 95%, P = 0. 002], Cox proportional hazards model developed in the adjusted Cox proportional hazards model, which utilized the substantially different variables from the univariate analysis and medications associated with HF. The conclusion was that a larger HRR in patients with permanent AF was correlated with HF events.
Source link: https://europepmc.org/article/MED/35751389
In patients with nonvalvular atrial fibrillation, we investigated the relationship between left atrial epicardial adipose tissue and left atrial appendage flow velocity. A total of 145 patients with NV-AF who underwent their first radiofrequency ablation were enrolled. Independent predictors of LAA-FV and type of atrial fibrillation were shown by a multiple linear regression model on LAA-FV's left atrial low voltage zone, LA-EAT volume, left atrial appendage shape, LAVI, and type of atrial fibrillation.
Source link: https://europepmc.org/article/MED/35750694
Patients treated with intravenous recombinant tissue plasminogen activator within 4. 5 hours after symptom onset were divided into a low-dose group and a standard-dose group, according to the recombinant tissue plasminogen activator dose. Patients with an AIS in the low-dose group and the standard dose group were divided into whether or not they had AF. With AF, the mRS score distribution showed a significant decline in patients with standard-dose recombinant tissue plasminogen activator than in those with low-dose recombinant tissue plasminogen activator. AF can be a predictor of poor prognosis in patients treated with standard-dose recombinant tissue plasminogen activator, causing the conclusion that patients with AF should have a low-dose recombinant tissue plasminogen activator to increase their prognosis.
Source link: https://europepmc.org/article/MED/35750486
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions